Avidity Biosciences, Inc.
NUCLEIC ACID COMPOSITIONS AND METHODS OF MULTI-EXON SKIPPING

Last updated:

Abstract:

Disclosed herein are oligonucleotide conjugates and pharmaceutical compositions for inducing multi-exon skipping. In some instances, also disclosed herein are methods of treating a muscular dystrophy, including treating Duchenne muscular dystrophy or Becker muscular dystrophy.

Status:
Application
Type:

Utility

Filling date:

24 Apr 2020

Issue date:

28 Jul 2022